A phase 2, double-blinded, placebo-controlled trial of toll-like receptor 7/8/9 antagonist, IMO-8400, in dermatomyositis
- Resource Type
- Short Communication
- Source
- In
Journal of the American Academy of Dermatology April 2021 84(4):1160-1162 - Subject
- Language
- ISSN
- 0190-9622